Overview
Compare with Pediatrix Medical Group, Magellan Health or Select Medical, or pick any stock.
- TickerJRSS on OTC1
- IndustryServices-Hospitals1
- HeadquartersZhongshan City, China1
- Incorporated inFL2
- Business address3/F Building A, Derun Yuan, No. 19 Changyi Road, Changmingshui, Wuguishan, Zhongshan City, F4 5284582
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
“JRSIS–BVI” identifies JRSIS Health Care Limited, a wholly-owned subsidiary of JRSIS that is organized in the British Virgin Islands (“BVI”).4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue86¢$3.0M
- Research and development5¢$189.3K
- Other costs7¢$228.4K
- Interest2¢$56.4K
- Income tax0¢$9.0K
Out of $3.5M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2023
- Capital spending0¢$1.5K
- Kept or used elsewhere100¢$515.2K
Out of $516.7K of cash from operations.5
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $24.1M6 | $28.4M7 | $31.5M8 | $35.7M9 | $44.4M9 | $1.7M5 | $3.5M5 |
| Cost of revenue | $7.1M6 | $1.7M5 | $3.0M5 | ||||
| Gross profit | $26.2K5 | $483.1K5 | |||||
| Research and development | $283.0K5 | $189.3K5 | |||||
| Operating expenses | $711.0K5 | $671.6K5 | |||||
| Operating income | $6.7M7 | $6.0M10 | $4.7M8 | $5.6M9 | -$103.8K11 | -$684.8K5 | -$188.6K5 |
| Interest | $1.3M7 | $1.1M10 | $1.1M8 | $1.1M9 | $1.4M9 | $64.7K5 | $56.4K5 |
| Income before tax | -$103.8K11 | -$673.3K5 | -$85.6K5 | ||||
| Income tax | $2.5K7 | $2.8M10 | $657.7K8 | $1.4M9 | $1.2M9 | $9.0K5 | |
| Net income | $4.6M7 | $2.0M10 | $888.1K8 | $3.8M9 | $3.2M11 | -$575.8K5 | -$80.9K5 |
| Earnings per share | $0.1310 | $0.058 | $0.159 | $0.1711 | -$0.015 | -$0.005 | |
| Earnings per share (diluted) | $0.1310 | $0.058 | $0.159 | $0.1711 | -$0.015 | -$0.005 | |
| Shares (weighted, basic) | 18.5M shares11 | 61.3M shares5 | 77.3M shares5 | ||||
| Shares (weighted, diluted) | 18.7M shares11 | 61.3M shares5 | 77.3M shares5 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $884.3K10 | $256.4K8 | $2.0M8 | $844.8K9 | $29.8K11 | $58.6K11 | $118.1K5 |
| Receivables | $7.5M9 | $683.5K5 | $714.7K5 | ||||
| Inventory | $1.8M9 | $562.0K5 | $455.2K5 | ||||
| Current assets | $10.3M7 | $12.0M10 | $9.5M8 | $7.9M9 | $13.9M11 | $1.7M5 | $1.8M5 |
| Property, plant and equipment | $33.2M9 | $62.2K5 | $50.0K5 | ||||
| Intangible assets | $303.2K5 | $257.3K5 | |||||
| Total assets | $48.7M7 | $52.5M10 | $51.6M8 | $58.8M9 | $75.7M11 | $2.0M5 | $2.1M5 |
| Accounts payable | $66.0K11 | $24.7K11 | |||||
| Short-term debt | $49.7K5 | $18.7K5 | |||||
| Current liabilities | $5.1M7 | $7.2M10 | $10.9M8 | $11.8M9 | $17.6M11 | $2.1M5 | $2.3M5 |
| Long-term debt | $24.9K5 | ||||||
| Total liabilities | $28.4M7 | $30.4M10 | $28.6M8 | $30.0M9 | $42.6M11 | $2.1M5 | $2.3M5 |
| Retained earnings | -$1.9M11 | -$3.4M5 | -$3.4M5 | ||||
| Shareholders’ equity | $12.9M7 | $14.1M10 | $14.8M8 | $19.0M9 | $22.1M11 | -$58.5K5 | -$137.4K5 |
| Shares outstanding | 14.8M shares6 | 15.0M shares10 | 18.0M shares8 | 18.2M shares9 | 18.6M shares11 | 76.8M shares5 | 82.6M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $8.3M7 | $9.2M10 | $11.8M8 | $10.6M9 | $8.2M11 | -$1.8M5 | $516.7K5 |
| Depreciation and amortization | $5.8K11 | $53.8K5 | |||||
| Stock-based compensation | $245.5K11 | ||||||
| Capital spending | $2.6M7 | $3.3M10 | $4.7M8 | $8.3M9 | $2.3M9 | $44.6K11 | $1.5K5 |
| Free cash flow | $5.7M | $5.9M | $7.1M | $2.4M | $5.9M | -$1.8M | $515.2K |
| Cash from investing | -$5.5M11 | -$2.8M11 | $18.9K5 | ||||
| Cash from financing | -$2.8M11 | $1.9M5 | -$568.4K5 | ||||
| Dividend per share | $0.0111 |
Corporate structure
JRSIS HEALTH CARE Corp sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of JRSIS HEALTH CARE Corp
- Zhuowei Zhong Filed SC 13D on JRSIS HEALTH CARE Corp, latest Jun 28, 2022
- JRSIS HEALTH CARE Corp Zhongshan City, China
- in the People’s Republic of Subsidiary · China
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What JRSIS HEALTH CARE Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $147.6K5 Dec 31, 2023 | $240.8K5 Dec 31, 2022 | −38.7% |
| Accumulated depreciation | $97.6K5 Dec 31, 2023 | $178.6K5 Dec 31, 2022 | −45.4% |
| Property and equipment, net | $50.0K5 Dec 31, 2023 | $62.2K5 Dec 31, 2022 | −19.6% |
| Operating-lease assets (leased space) | $3.3K5 Dec 31, 2023 | $7.7K5 Dec 31, 2022 | −57.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $58.6K11 Dec 31, 2022 | $29.8K11 Dec 31, 2021 | +96.4% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $257.3K5 Dec 31, 2023 | $303.2K5 Dec 31, 2022 | −15.1% |
| Finite-lived intangibles, gross | $372.0K5 Dec 31, 2023 | $383.0K5 Dec 31, 2022 | −2.9% |
| Accumulated amortization | -$114.7K5 Dec 31, 2023 | -$79.8K5 Dec 31, 2022 | −43.8% |
| Finite-lived intangibles, net | $257.3K5 Dec 31, 2023 | $303.2K5 Dec 31, 2022 | −15.1% |
Inventory
Leadership
Who has led JRSIS HEALTH CARE Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerLihua Sun Nov 20, 2014 to Jan 9, 201515
- PresidentZhuowei Zhong Jul 5, 2022 to Jul 5, 202216
- PresidentJunsheng Zhang Nov 20, 2014 to Jan 9, 201517
- Chief financial officerZhuowen Chen Jul 5, 2022 to Jul 5, 202218
- Chief financial officerXuewei Zhang Nov 20, 2014 to Jan 9, 201519
Board members and other officers (6)
- Board memberZhuowei Zhong Jul 5, 2022 to Jul 5, 202216
- Board memberZhuowen Chen Jul 5, 2022 to Jul 5, 202218
- Board memberJunsheng Zhang Nov 20, 2014 to Jan 9, 201517
- Board memberLihua Sun Nov 20, 2014 to Jan 9, 201515
- Board memberXuewei Zhang Nov 20, 2014 to Jan 9, 201519
- Board memberYanhui Xing Nov 20, 2014 to Jan 9, 201520
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- in the People’s Republic of China3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Apr 11, 20248-K Change of auditor21
- Dec 11, 20238-K Executive or director change22
- Dec 1, 20238-K Entered a material agreement; Unregistered sale of shares; Change in control23
- Oct 18, 20238-K Entered a material agreement24
- Aug 7, 20238-K Change of auditor25
- Jun 29, 20238-K Bylaws or fiscal year changed26
- Jun 9, 20228-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares27
- Nov 23, 20218-K Other events28
- Nov 20, 2014New chief executive Lihua Sun becomes CEO15
Filings
47 filings to the SEC since October 2021: 5 annual reports, 10 quarterly reports, 8 major events, 3 insider forms, 1 large holders, 20 other. The latest 20:
- Mar 3, 202515-12G EDGAR
- Dec 20, 202410-Q QUARTERLY REPORT EDGAR
- Nov 14, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Sep 5, 202410-Q QUARTERLY REPORT EDGAR
- Aug 15, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- May 29, 202410-Q QUARTERLY REPORT EDGAR
- May 16, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Apr 26, 202410-K ANNUAL REPORT EDGAR
- Apr 11, 20248-K CURRENT REPORT EDGAR
- Mar 29, 2024NT 10-K NOTIFICATION OF LATE FILING EDGAR
- Dec 11, 20238-K CURRENT REPORT EDGAR
- Dec 1, 20238-K CURRENT REPORT EDGAR
- Nov 15, 202310-Q QUARTERLY REPORT EDGAR
- Nov 14, 2023NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Oct 18, 20238-K CURRENT REPORT EDGAR
- Sep 29, 2023UPLOAD EDGAR
- Aug 31, 2023CORRESP EDGAR
- Aug 31, 202310-K/A AMENDMENT NO. 2 TO FORM 10-K EDGAR
- Aug 28, 2023UPLOAD EDGAR
- Aug 21, 202310-Q QUARTERLY REPORT EDGAR
The 47 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Zhuowei ZhongSC 13D, 1 filing Jun 28, 202229
SEC filer profile
How JRSIS HEALTH CARE Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARJRSIS HEALTH CARE Corp1
- CIK0001597892
- Employer ID (EIN)46-45620471
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inFlorida1
- Fiscal year endsDecember 311
- Industry code (SIC)8060 Services-Hospitals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address3/F Building A, Derun Yuan, No. 19 Changyi Road, Changmingshui, Wuguishan, Zhongshan City, F4 5284581
- Phone0760-889636581
- Shares outstanding84,598,650 as of Dec 20, 202414
- Public float$5.6M as of Jun 30, 20235
- On EDGAR sinceMar 6, 20141
- Filings163 in all: 8-K (34), 10-Q (31), UPLOAD (11), 10-K (10), CORRESP (10), NT 10-Q (10), EFFECT (9), POS AM (8)1
All 23 form types
S-1/A (8), 3 (7), NT 10-K (6), 5 (4), 10-K/A (2), DEF 14A (2), DEFA14A (2), S-1 (2), 15-12G (1), 8-A12B (1), 8-A12G (1), DEF 14C (1), PRE 14C (1), SC 13D (1), SPDSCL (1)
- Latest filingsAnnual report (10-K) Apr 26, 2024
Quarterly report (10-Q) Dec 20, 2024
Proxy statement (DEF 14A) Oct 22, 2020
Latest 8-K (8-K) Apr 11, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARLihua Sun, Chief executive officer
- 16SEC EDGARZhuowei Zhong, President
- 17SEC EDGARJunsheng Zhang, President
- 18
- 19
- 20SEC EDGARYanhui Xing, Board member
- 21SEC EDGARChange of auditor
- 22SEC EDGARExecutive or director change
- 23
- 24SEC EDGAREntered a material agreement
- 25SEC EDGARChange of auditor
- 26SEC EDGARBylaws or fiscal year changed
- 27
- 28SEC EDGAROther events
- 29